Alerte De Sécurité sur Optium Xceed

Selon Department of Health, ce/cet/cette alerte de sécurité concerne un dispositif en/au/aux/à Hong Kong qui a été fabriqué par Abbott.

Qu'est-ce que c'est?

Les alertes fournissent des informations importantes et des recommandations concernant les dispositifs médicaux. Le fait qu'une alerte soit émise ne signifie pas nécessairement qu'un dispositif soit dangereux. Les alertes de sécurité, qui sont envoyées tant aux travailleurs du secteur médical qu'aux utilisateurs de ces dispositifs, peuvent inclure des rappels. Elles peuvent être rédigées par des fabricants mais aussi par des autorités en charge de la santé.

En savoir plus sur les données ici
  • Type d'événement
    Safety alert
  • Date
  • Pays de l'événement
  • Source de l'événement
  • URL de la source de l'événement
  • Notes / Alertes
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • Notes supplémentaires dans les données
    Press release
  • Cause
    Medical device alert for blood glucose meters the department of health (dh) was notified by the food and drug administration of the united states today (september 11) about a worldwide medical device alert on a type of blood glucose meters, the display screen of which may not work properly when dropped onto a hard surface. a dh spokesman said the alert was initiated by the manufacturer, abbott diabetes care, involving blood glucose meters manufactured after january 2007. the display screen of the affected meters, marked as "abbott optium xceed", may not work properly or may appear blank if dropped on a hard surface, thus making the users unable to view the blood glucose test results. it was revealed that a total of 857 affected devices were sold in hong kong but none of them were released to hospitals. as a precautionary measure, users should not use the blood glucose monitor if the display shows missing or blank section. they should contact the local agent or supplier for replacement. "users should ensure a full display show each time the blood glucose monitor is turned on, especially before using the monitor to check the blood glucose level," the spokesman said. the spokesman said dh had alerted the hospital authority, private hospitals, nursing homes and medical professional associations to this medical device correction. dh has not received any report of adverse events arising from this issue. the spokesman said members of the public using the meters concerned should contact the local agent by calling its hotline 2806 4488 during office hours for advice. relevant information is available at the manufacturer's website. ends/tuesday, september 11, 2007 nnnn.


  • Modèle / numéro de série
  • Description du dispositif
    Press release: Medical Device Alert for Blood Glucose Meters
  • Manufacturer


  • Société-mère du fabricant (2017)
  • Commentaire du fabricant
    “We are in constant communication with regulatory agencies and competent authorities worldwide which allows us to implement global recalls or in-country communication quickly and effectively,” Abbott, which now owns St. Jude Medical told ICIJ in a statement. In addition to sending global notices to physicians worldwide, we also make sure that product advisories are available online and classification of product recalls and product advisories are determined by global regulatory bodies which can impact the timing in any given country. MD companies follow varying regulations in different countries. In come countries software is not regulated so a recall in one country related to software would not be classified as a recall or field action in another. In addition, review cycles within the regulatory process can be different in each country which can impact communication and recall timing.
  • Source